Literature DB >> 24732657

The essential role of T cells in multiple sclerosis: a reappraisal.

Cris S Constantinescu1, Bruno Gran.   

Abstract

Multiple sclerosis is an inflammatory demyelinating disease of the central nervous system in which destruction of myelin and nerve axons has been shown to be mediated by immune mechanisms. Although the focus of research has been traditionally on T cells as key mediators of the immunopathology, more recent efforts at understanding this complex disorder have been directed increasingly at other cellular and humoral elements of the immune response. This review is a reappraisal of the crucial role of T cells, in particular the CD4+ helper T-cell subset, in multiple sclerosis. Recent evidence is discussed underlining the predominant contribution of T-cell-associated genes to the genome-wide association study results of multiple sclerosis susceptibility, the loss of T-cell quiescence in the conversion from clinically isolated syndrome to clinically definite multiple sclerosis, and the fact that T cells represent the main target of effective immunomodulatory and immunosuppressive treatments in multiple sclerosis.

Entities:  

Mesh:

Year:  2014        PMID: 24732657     DOI: 10.4103/2319-4170.128746

Source DB:  PubMed          Journal:  Biomed J        ISSN: 2319-4170            Impact factor:   4.910


  13 in total

Review 1.  Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications.

Authors:  Stefan Bittner; Heinz Wiendl
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 2.  The role of melatonin in Multiple Sclerosis.

Authors:  Charalampos Skarlis; Maria Anagnostouli
Journal:  Neurol Sci       Date:  2019-12-16       Impact factor: 3.307

3.  DAB389IL-2 recombinant fusion toxin effect on lymphocyte- and macrophage-producing cytokine subpopulation cells in experimentally induced demyelinating disease in mice.

Authors:  Mahendra K Bhopale; Brendan Hilliard; Cris S Constantinescu; S Michael Phillips; Abdolmohamad Rostami
Journal:  Immunopharmacol Immunotoxicol       Date:  2017-09-20       Impact factor: 2.730

Review 4.  Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes.

Authors:  Jan Lycke
Journal:  Ther Adv Neurol Disord       Date:  2015-11       Impact factor: 6.570

5.  Hookworm Treatment for Relapsing Multiple Sclerosis: A Randomized Double-Blinded Placebo-Controlled Trial.

Authors:  Radu Tanasescu; Christopher R Tench; Cris S Constantinescu; Gary Telford; Sonika Singh; Nanci Frakich; David Onion; Dorothee P Auer; Bruno Gran; Nikos Evangelou; Yasser Falah; Colin Ranshaw; Cinzia Cantacessi; Timothy P Jenkins; David I Pritchard
Journal:  JAMA Neurol       Date:  2020-09-01       Impact factor: 18.302

6.  Reciprocal Regulation of Substance P and IL-12/IL-23 and the Associated Cytokines, IFNγ/IL-17: A Perspective on the Relevance of This Interaction to Multiple Sclerosis.

Authors:  Janek Vilisaar; Kiyokazu Kawabe; Manjit Braitch; Jehan Aram; Yasemin Furtun; Angela J Fahey; Mark Chopra; Radu Tanasescu; Patrick J Tighe; Bruno Gran; Charalabos Pothoulakis; Cris S Constantinescu
Journal:  J Neuroimmune Pharmacol       Date:  2015-02-18       Impact factor: 4.147

7.  Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients.

Authors:  Helena Posová; Dana Horáková; Václav Čapek; Tomáš Uher; Zdenka Hrušková; Eva Havrdová
Journal:  BMC Neurol       Date:  2017-07-28       Impact factor: 2.474

8.  The Soluble Form of Toll-Like Receptor 2 Is Elevated in Serum of Multiple Sclerosis Patients: A Novel Potential Disease Biomarker.

Authors:  Md Jakir Hossain; Elena Morandi; Radu Tanasescu; Nanci Frakich; Marzia Caldano; David Onion; Tola A Faraj; Clett Erridge; Bruno Gran
Journal:  Front Immunol       Date:  2018-03-14       Impact factor: 7.561

Review 9.  The Role of MicroRNAs in Repair Processes in Multiple Sclerosis.

Authors:  Conor P Duffy; Claire E McCoy
Journal:  Cells       Date:  2020-07-16       Impact factor: 6.600

10.  Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers.

Authors:  Olaf Stuve; Per Soelberg Soerensen; Thomas Leist; Gavin Giovannoni; Yann Hyvert; Doris Damian; Fernando Dangond; Ursula Boschert
Journal:  Ther Adv Neurol Disord       Date:  2019-06-18       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.